BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 20, 2016
View Archived Issues
Galapagos updates on progress of cystic fibrosis candidates
Read More
Neurotrophic factor-secreting autologous MSCs show promising clinical results in ALS
Read More
Acetazolamide counters effects of Klotho hypomorphism on aging
Read More
Lilly files NDA for baricitinib for the oral treatment of rheumatoid arthritis
Read More
Adimab and iTeos to develop therapeutic antibodies for cancer
Read More
Berkeley Lights ships OptoSelect antibody discovery instrument to Amgen
Read More
FDA awards fast track designation to ZX-008 for Dravet syndrome
Read More
CEVEC and Beckman Research Institute sign collaboration agreement for CAPGT technology
Read More
First patient dosed in phase I trial evaluating TP-271
Read More
DNAzymes can be used for molecular probes to detect specific bacterial strains
Read More
EMA grants orphan drug designation to ARC-AAT
Read More
Sunshine Lake Pharma reports anti-HCV NS5B inhibitors
Read More
Hybrid Medical's gel H-100 evaluated in patients with Peyronie's disease
Read More
Trevena launches phase III clinical program for oliceridine
Read More
Pierre Fabre develops antitumor OSW-1 derivatives
Read More
Oncaspar receives marketing authorization in the E.U. as combination therapy for ALL
Read More
Roche presents ENT1 inhibitors
Read More
Profectus BioSciences initiates phase I testing of a vectored Ebola virus vaccine
Read More
Takeda develops FFAR2 agonists
Read More
Mologen and MD Anderson collaborate in trial of lefitolimod + ipilimumab
Read More
Aclaris Therapeutics starts phase III trials for A-101 in seborrheic keratosis
Read More
Gilead presents PI3Kdelta inhibitors
Read More
NIDA to conduct research on RespireRx compounds to treat drug abuse and addiction
Read More
Saniona and Upsher-Smith form neurological drug discovery and development collaboration
Read More